Tag: us fda on glenmark aurangabad facility

[ad_1] Shares of Glenmark Pharmaceuticals Ltd. surged by as much as 9% during Monday’s trading session. The sharp uptick in the stock price was seen after the US Food and Drug Administration (FDA) issued a Form 483 with zero observations for the company’s manufacturing facility in Chhatrapati Sambhaji Nagar (Aurangabad). The US FDA conducted […]